Project Grant 2409808
Award Date
7/1/24
Completion Date
6/30/25
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
Quarksen LLC (R2XKUC52Q7N5)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Boston, MA 02135, USA
Similar Awards
This $274,362 Project Grant awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel molecular diagnostic platform for detecting respiratory diseases, including strep throat, without the need for an expensive table-top device. The platform aims to provide the accuracy of laboratory-based tests for use by non-healthcare professionals in non-clinical settings, enabling rapid and reliable...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is focused on developing an affordable, portable virus detection platform. The $331,189 project, awarded on April 1, 2025 and running through March 31, 2028, integrates protein engineering and electrochemical biosensor technologies to create a virus detection system that can operate in resource-limited environments. The innovation lies in using stable...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $300,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Baebies, Inc., a Durham, North Carolina-based medical diagnostics company. This funding will support the development of a rapid, point-of-care diagnostic test to identify viable sexually transmitted infections (STIs) and reduce overtreatment, thereby helping to prevent the emergence of antibiotic-resistant STI strains....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Sherlock Biosciences, Inc. a $298,948 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a power-free, molecular diagnostic device for detecting Chlamydia trachomatis and Neisseria gonorrhoeae from self-collected vaginal swabs. The project aims to create an accessible, accurate, and affordable at-home testing solution for sexually transmitted infections (STIs) that does not...
This $305,000 Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a point-of-care diagnostic platform by Resonantia Diagnostics, Inc. that can rapidly identify pathogens and determine their antimicrobial susceptibility within 60 minutes. The key technical objectives of this 1-year project are to: (1) demonstrate accurate antimicrobial susceptibility testing at low pathogen loads, (2)...
Under a $997,781 cooperative agreement awarded by the National Science Foundation (NSF) through its Technology, Innovation, and Partnerships (CFDA 47.084) program, Nanopath Inc. - a woman-owned small business - is developing an integrated point-of-care system for rapid pathogen identification and characterization. The system utilizes proprietary nanosensor technology to detect target nucleic acid sequences directly from patient samples, eliminating the need for bacterial culture or nucleic...
This $1,200,000 Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) aims to develop innovative diagnostic sensing technologies that can enable more frequent and comprehensive health monitoring. The key products and services to be delivered under this award include: Integrating DNA nanotechnology and CMOS electronics to create highly sensitive and easy-to-use biosensing platforms that can detect a wider range...
This National Science Foundation Project Grant of $180,493 will support the development of an ultrasensitive point-of-care diagnostic system using clustered regularly interspaced short palindromic repeats (CRISPR) technology for early disease detection without pre-amplification of viral genomes. Funded under the NSF's Office of Integrative Activities program (CFDA 47.083), which enhances STEM competitiveness through capacity building and broadening participation, this 24-month project will...
This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...
The National Science Foundation (NSF) awarded a $650,000 project grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to the University of Nevada, Reno to establish a point-of-care (POC) platform technology using smartphone-based time-resolved luminescence imaging and detection (STRIDE) enabled by manganese-doped semiconductor nanocrystals and artificial intelligence. This 1-year project will: (1) further develop the photophysics and optical properties of the...